Four well-known stock pickers, with a proven track record for finding multibagger stocks, have recommended 17 top-quality stocks for investment with the solemn assurance that the stocks will sparkle and shower hefty gains on investors
Posts tagged Shilpa Medicare
Fav “Pole Position” Stock Of Dolly Khanna & Sunil Singhania Has Huge Upside Potential: Experts
When four eminent stock pickers of proven caliber declare confidence in a stock, more research is not required to be done because it is certain that hefty gains will gush out of the stock sooner or later. Nevertheless, leading experts have analyzed the stock and confirmed that it is indeed a good buy
Motilal Oswal Downgrades Raamdeo Agrawal’s Fav Stock
Raamdeo Agrawal, the boss man of Motilal Oswal, recommended a stock on the basis that it has a huge “competitive advantage” and other stellar virtues. Unfortunately, the stock now faces the ignominy of being downgraded by Motilal Oswal itself owing to “competitive pressures ”
Forget Lottery Tickets, Buy Pharma Stocks Now For Mega Gains: Rakesh Jhunjhunwala
Pharma stocks have lost favour amongst investors owing to the USFDA regulatory headwinds. However, this is the opportune time to buy these stocks because they have several years of strong growth in them say Rakesh Jhunjhunwala and Raamdeo Agrawal
Manish Bhandari Of Vallum Rakes In 1100% (In 18M) And Announces New Stock Picks
Manish Bhandari’s PMS has reported a spectacular performance with some stocks blowing off the ceiling with up to 11x gains in just 18 months. He has also announced the addition of new stocks to the portfolio, which we have to keep an eagle eye on
Daljeet Kohli Condemns Fav Contra Stock Of Sanjoy Bhattacharyya & Saurabh Mukherjea Even As “100 Bagger” Pharma Stock Surges
A mid-cap Pharma stock strongly recommended by Sanjoy Bhattacharyya & Saurabh Mukherjea is facing the ignominy of being declared a flop. Luckily, another “100 Bagger” Pharma stock is surging and bringing cheer to investors
Daljeet Kohli’s Fav “100-Bagger” Mid-Cap Pharma Stock Is “Ripe For Re-Rating” & Is Back In The Buy Zone
A mid-cap Pharma stock has become the favourite of several ace stock pickers because of it’s dominance in the market place, high RoEs, quality management and reasonable valuations. The stock is also proclaimed as a potential 100-bagger stock. Daljeet Kohli claims the stock is a good buy now because it is “ripe for re-rating“
Check Out The Multi-Bagger Stock Picks Of Mr. Motilal Oswal For 2016 & Beyond
Motilal Oswal, the founder of MOFSL, has recommended five large-cap stocks and five small-cap stocks which he believes have the potential to give multi-bagger gains and create huge wealth for their shareholders
Lucky 13 Stock Picks For 2016 By Outlook Business’ 13 Stock Wizards
Outlook Business’ most eagerly awaited feature is the one where they invite leading stock experts to indicate their favourite stocks for the coming year. For 2016, Outlook Business has persuaded 13 eminent wizards to recommend 13 top-quality stocks
“100-Bagger” Stocks Are On The March! Are We Keeping Pace?
Nearly a year has passed since Motilal Oswal’s recomm endation of seven potential 100-Bagger stocks. The time is opportune to take account of the performance of the stocks and see what the future holds for them
Recent Comments